Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Badajoz
Clinical trial register · Spain

Clinical Trials in Badajoz, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca12 Eli Lilly and Company9 Fundación EPIC5 GlaxoSmithKline4 BioNTech SE3
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Badajoz

91 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
AstraZeneca
Phase 3
2,800
Badajoz, Barcelona, Córdoba, Girona, Madrid, Majadahonda, Talavera de la Reina, Valencia
2026-09-01
Recruiting
AstraZeneca
Phase 3
7,000
Badajoz, Barcelona, Burgos, Córdoba, Granada, Madrid, Majadahonda, Málaga
2026-08-21
Recruiting
AstraZeneca
Phase 3
150
Badajoz, Badalona, Barcelona, Burgos, Donostia / San Sebastian, Huelva, Jaén, Las Palmas de Gran Canaria
2026-06-15
Recruiting
Occurrence of Peri-Implant Complications: A Multifactorial Cross-Sectional Study
NCT07638969Peri-Implantitis and Peri-implant Mucositis
Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain
Observational
150
Badajoz
2026-06-06
Recruiting
Merck Sharp & Dohme LLC
Phase 3
876
L'Hospitalet de Llobregat, Barakaldo, Barcelona, Málaga, Badajoz, Madrid, Seville, Valencia
2026-05-04
Recruiting
University of Extremadura
Not applicable
40
Badajoz
2026-04-14
Recruiting
MediLink Therapeutics (Suzhou) Co., Ltd.
Phase 1/2
118
Badajoz, Badalona, Barcelona, Girona, Madrid, Manresa, Seville, Valencia
2026-03-31
Not yet open
Treatment for Ph-negative ALL for Adults up to 65 Years
NCT07443592Acute Lymphoblastic Leukemia
PETHEMA Foundation
Not applicable
330
A Coruña, Alava, Albacete, Alicante, Almería, Arrecife, Ávila, Badajoz
2026-03-06
Recruiting
Effect of Intravenous Iron on Quality of Life in Older Patients With Acute Coronary Syndrome
NCT07476859Acute Coronary Syndromes (ACS), Iron Deficiencies, Elderly (People Aged 65 or More)
DrugsFerinject·Ferric Carboxymaltose
Fundación para la Investigación del Hospital Clínico de Valencia
Phase 4
538
El Palmar, Vigo, Badajoz, Barcelona, Granada, León, Madrid, Pamplona
2026-03-05
Recruiting
SOLTI Breast Cancer Research Group
Phase 2
300
Barcelona, A Coruña, Alicante, Badajoz, Bilbao, Girona, Granada, L'Hospitalet de Llobregat
2026-02-18
Active, closed
Metabolic Response to Supine Physiotherapy in Mechanically Ventilated ICU Patients
NCT07361419Critical Illness, Mechanical Ventilation, Intensive Care Unit-Acquired Weakness, Physical Rehabilitation in the Intensive Care Unit
Universidad de Extremadura
Observational
40
Badajoz
2026-02-01
Recruiting
Eli Lilly and Company
Phase 3
800
Badajoz, Barcelona, Cáceres, Donostia / San Sebastian, Granada, Hospitalet, Jaén, Las Palmas de Gran Canaria
2025-12-22
Recruiting
UNICANCER
Phase 3
3,902
Badajoz, Barcelona, Bilbao, Fuenlabrada, Granada, Jaén, Jerez de la Frontera, L'Hospitalet de Llobregat
2025-12-18
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
DrugsVepugratinib·Pembrolizumab
Eli Lilly and Company
Phase 3
450
Badajoz, Badalona, Barakaldo, Barcelona, Córdoba, Elche, Girona, Hospitalet
2025-12-12
Recruiting
Ventus Therapeutics U.S., Inc.
Phase 2
24
Badajoz, Madrid
2025-12-03
Recruiting
Eli Lilly and Company
Phase 3
7,140
Almería, Alzira, Badajoz, Badalona, Barcelona, Boadilla del Monte, Lugo, Majadahonda
2025-12-01
Recruiting
BioNTech SE
Phase 3
558
Badajoz, Barcelona, Córdoba, Madrid, Murcia, Pamplona, Sabadell, Valencia
2025-10-30
Recruiting
Bristol-Myers Squibb
Phase 2/3
470
Barcelona, Santander, Madrid, Valencia, Badajoz, Córdoba, Seville
2025-09-30
Recruiting
Pfizer
Phase 3
680
A Coruña, Badalona, Barcelona, Madrid, Badajoz, Granada, Palma, Seville
2025-09-29
Recruiting
Alnylam Pharmaceuticals
Phase 3
11,000
A Coruña, Alcalá de Henares, Alicante, Antequera, Badajoz, Barcelona, Burjassot, Cadiz
2025-09-22
Active, closed
AstraZeneca
Phase 3
68
A Coruña, Badajoz, Barakaldo, Barcelona, Madrid, Málaga, Oviedo, Santander
2025-09-15
Not yet open
Universidad de Extremadura
Not applicable
220
Badajoz
2025-09-01
Recruiting
Relay Therapeutics, Inc.
Phase 3
540
Badajoz, Badalona, Barcelona, Castellon, Cáceres, El Palmar, Girona, Huelva
2025-08-26
Recruiting
Celcuity Inc
Phase 3
1,180
A Coruña, Badajoz, Barcelona, Cáceres, El Palmar, L'Hospitalet de Llobregat, Lleida, Madrid
2025-07-24
Active, closed
Novartis Pharmaceuticals
Phase 2
168
Santander, Badajoz, Lugo, Barcelona, Córdoba
2025-07-07
Recruiting
GlaxoSmithKline
Phase 1/2
85
Badajoz, Barcelona, Madrid, Málaga, Pozuelo de AlarcOn Madr
2025-06-12
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 3
450
Badajoz, Barakaldo, Barcelona, Cadiz, Córdoba, Granada, Madrid, Málaga
2025-05-19
Active, closed
Eli Lilly and Company
Phase 3
465
Badajoz, Badalona, Barcelona, Madrid, Seville
2025-05-12
Recruiting
Fundación EPIC
Observational
500
Albacete, Alicante, Badajoz, Castelló, Ciudad Real, Elche, L'Hospitalet de Llobregat, Laguna
2025-05-06
Not yet open
Muscle Oxygen Saturation and Functional Capacity in Breast Cancer Survivors
NCT06976593Breast Cancer Survivorship, Muscle Oxygenation, Near-infrared Spectroscopy, Exercise
University of Extremadura
Observational
30
Badajoz
2025-05-05
Recruiting
Optimising TREATment for Severe Gram-Negative Bacterial Infections
NCT07004049Bloodstream Infection, Ventilator Associated Bacterial Pneumonia, Hospital Acquired Bacterial Pneumonia, Carbapenem Resistant Bacterial Infection
DrugsCeftolozane-tazobactam·Cefiderocol·Fosfomycin·Meropenem-Vaborbactam
National University of Singapore
Phase 4
600
Alicante, Badajoz, Barakaldo, Barcelona, Córdoba, Granada, Madrid, Málaga
2025-04-21
Recruiting
AstraZeneca
Phase 3
830
Badajoz, Badalona, Barcelona, Castellon, Granada, Jaén, Lugo, Madrid
2025-04-10
Recruiting
Eli Lilly and Company
Phase 3
700
Badajoz, Barcelona, Hospitalet, Jerez de la Frontera, Las Palmas de Gran Canaria, Madrid, Málaga, Palma
2025-03-27
Recruiting
Summit Therapeutics
Phase 3
780
Barakaldo, Santander, Badajoz, Las Palmas, Madrid, Sevilla, Marbella, Seville
2025-02-27
Recruiting
BioNTech SE
Phase 3
621
Badajoz, Barcelona, Castellon, León, Madrid, Málaga, Seville, Torrejón de Ardoz
2025-02-03
Active, closed
argenx
Phase 3
631
Vitoria-Gasteiz, Badajoz, Barcelona, Santiago de Compostela, Madrid, A Coruña, Seville, Valencia
2025-01-15
Recruiting
BioNTech SE
Phase 2/3
1,580
A Coruña, Badajoz, Badalona, Barcelona, Castellon, Las Palmas de Gran Canaria, León, Lleida
2025-01-07
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Badajoz, Barcelona, Madrid, Málaga, Pamplona, Seville, Valencia
2024-12-12
Recruiting
UCB Biopharma SRL
Phase 3
450
A Coruña, Badajoz, Barcelona, Castellon, Madrid, Málaga, Mérida, Sabadell
2024-11-21
Recruiting
AbbVie
Phase 2
488
Badajoz, Barcelona, Madrid, Valencia
2024-10-07
Recruiting
GlaxoSmithKline
Phase 1
845
Badajoz, Barcelona, Madrid, Málaga, Valencia, Zaragoza
2024-09-30
Recruiting
Study on the Effect of a Gamified Health Education Programme on Primary School Children
NCT07276412Gamification in Health Education, Health Education
Universidad de Extremadura
Not applicable
500
Badajoz
2024-09-02
Recruiting
Jazz Pharmaceuticals
Phase 3
550
A Coruña, Badajoz, Barcelona, Elche, Granada, Madrid, San Cristóbal de La Laguna, Seville
2024-08-13
Recruiting
Fundación EPIC
Not applicable
150
Alicante, Badajoz, Huelva, Seville
2024-05-31
Recruiting
Fundación para la Investigación del Hospital Clínico de Valencia
Observational
70
Alicante, Badajoz, Barcelona, Candelaria, Castellon, Málaga, Murcia, Palma de Mallorca
2024-03-21
Recruiting
Eli Lilly and Company
Phase 3
1,264
A Coruña, Badajoz, Barakaldo, Barcelona, Hospitalet, Jerez de la Frontera, Las Palmas de Gran Canaria, León
2023-12-21
Active, closed
OP-1250 (Palazestrant) vs. Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
NCT06016738Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
DrugsPalazestrant·Exemestane·Anastrozole·Letrozole
Olema Pharmaceuticals, Inc.
Phase 3
510
Badajoz, Badalona, Manresa, Girona, León, Lleida, Madrid, Pamplona
2023-11-16
Active, closed
Summit Therapeutics
Phase 3
1,600
Badajoz, Badalona, Barcelona, Girona, Jaén, Las Palmas de Gran Canaria, Lugo, Madrid
2023-10-26
Recruiting
Abbott Medical Devices
Observational
1,000
Badajoz, Barcelona, Huelva, Las Palmas, Majadahonda, Málaga, Valencia
2023-09-29
Active, closed
Seagen, a wholly owned subsidiary of Pfizer
Phase 3
412
Badalona, L'Hospitalet de Llobregat, Barakaldo, Santander, Majadahonda, Badajoz, Barcelona, L'Hospitaler de Llobregat
2023-09-22
Recruiting
Coroflex® ISAR NEO PMCF Study
NCT05698732Coronary Artery Disease (CAD), Ischemic Heart Disease
Fundación EPIC
Observational
3,000
A Coruña, Badajoz, Badalona, Barakaldo, Barcelona, Cáceres, Ciudad Real, Huelva
2023-08-04
Recruiting
GlaxoSmithKline
Phase 3
892
Badajoz, BaracaldoVizcaya, Barcelona, Córdoba, Donostia / San Sebastian, Elche Alicante, Granada, Jaén
2023-08-01
Active, closed
Mineralys Therapeutics Inc.
Phase 3
1,076
Badajoz, Córdoba, Granada, Valencia
2023-07-14
Recruiting
AstraZeneca
Phase 3
4,300
A Coruña, Albacete, Alcoy, Alicante, Alzira, Badajoz, Badalona, Barakaldo
2023-03-31
Active, closed
Sequent Extended Study
NCT05788432Coronary Artery Disease, Ischemic Heart Disease
Fundación EPIC
Observational
2,040
Alava, Alicante, Badajoz, Badalona, Barakaldo, Barcelona, Cadiz, Castelló
2023-03-28
Active, closed
Hoffmann-La Roche
Phase 2
301
Barakaldo, Badajoz, Barcelona, Burgos, Madrid, Seville, Valencia
2023-02-03
Recruiting
Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer
NCT05982093Breast Cancer, HER2-negative Breast Cancer, Hormone Receptor Positive Tumor, Premenopausal Breast Cancer
DrugsElacestrant·Tamoxifen
SOLTI Breast Cancer Research Group
Phase 2
96
Badalona, L'Hospitalet de Llobregat, Vilanova, El Palmar, Badajoz, Barcelona, Cáceres, Madrid
2023-02-03
Recruiting
Greenwich LifeSciences, Inc.
Phase 3
2,250
Albacete, Alicante, Badajoz, Barcelona, Cáceres, Córdoba, El Palmar, Fuenlabrada
2022-12-16
Active, closed
Celcuity Inc
Phase 3
701
Madrid, Badajoz, Barcelona, Cáceres, Murcia, Santiago de Compostela
2022-12-08
Active, closed
SOLTI Breast Cancer Research Group
Phase 2
120
Badalona, Santa Cruz de Tenerife, A Coruña, Fuenlabrada, Móstoles, Badajoz, Barcelona, Bilbao
2022-11-25
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Not applicable
600
Badajoz, Las Palmas de Gran Canaria, Majadahonda
2022-10-27
Active, closed
GlaxoSmithKline
Phase 2
351
Badajoz, Badalona, Barcelona, Las Palmas de Gran Canar, Madrid, Málaga, PamplonaNavarra, Valencia
2022-10-14
Active, closed
Eli Lilly and Company
Phase 3
8,000
A Coruña, Alicante, Almería, Badajoz, Barcelona, Bilbao, Burgos, Cáceres
2022-10-04
Active, closed
AbbVie
Phase 2
125
A Coruña, Badalona, Córdoba, Pamplona, Badajoz, Barcelona, Lleida, Madrid
2022-09-28
Active, closed
Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer
NCT05403385Metastatic NSCLC - Non-Small Cell Lung Cancer, Locally Advanced NSCLC - Non-Small Cell Lung Cancer
DrugsPemetrexed·Carboplatin
iTeos Therapeutics
Phase 2
36
Palma de Mallorca, Pamplona, Valencia, A Coruña, Badajoz, Barcelona, Manresa, Ourense
2022-08-26
Active, closed
EMD Serono Research & Development Institute, Inc.
Phase 2
256
Badajoz, Barcelona, Córdoba, Elche, Lugo, Madrid, Manresa
2022-08-17
Active, closed
AstraZeneca
Phase 3
341
Badajoz, Badalona, Barcelona, Córdoba, Girona, Madrid, Majadahonda, Málaga
2022-08-03
Active, closed
Shanghai Henlius Biotech
Phase 3
511
Badajoz, Badalona, Barcelona, Córdoba, Madrid, Seville, Valdecilla, Valencia
2022-05-17
Active, closed
Eli Lilly and Company
Phase 3
925
Hospitalet, Madrid, Valencia, Badajoz, Seville
2022-04-14
Recruiting
Hospital Universitario de Fuenlabrada
Phase 4
216
Elche, Almería, Badajoz, Sant Joan Despí, Castellon, Ciudad Real, Córdoba, San Sebastián
2022-03-02
Active, closed
Center of Implantology, Oral and Maxillofacial Surgery, Badajoz, Spain
Not applicable
60
Badajoz
2022-01-01
Active, closed
Novartis Pharmaceuticals
Phase 3
210
Badajoz, Pozuelo de Alarcón, Oviedo, A Coruña, Barcelona, Madrid, Málaga, Zaragoza
2021-12-17
Recruiting
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
NCT05176483Renal Cell Carcinoma (RCC), Metastatic Castration-Resistant Prostate Cancer (mCRPC), Urothelial Carcinoma (UC), Solid Tumor
DrugsZanzalintinib·Relatlimab·Yervoy·Ipilimumab
Exelixis
Phase 1
1,394
Badajoz, Barcelona, L'Hospitalet de Llobregat, Madrid, Pamplona, Santander, Seville, Valencia
2021-12-14
Active, closed
Spanish Breast Cancer Research Group
Phase 3
27
A Coruña, Albacete, Alicante, Badajoz, Badalona, Barcelona, Bilbao, Cadiz
2021-09-14
Recruiting
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 3
434
Alicante, Badajoz, Badalona, Barcelona, Cadiz, Jaén, Madrid, Málaga
2021-07-06
Recruiting
Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
NCT04891237Rhinitis, Allergic, Rhinoconjunctivitis, Asthma, Allergic
Drugs10,000 MG01·30,000 MG01
Inmunotek S.L.
Phase 3
180
Tarancón, Alcalá de Henares, Tres Cantos, Valdemoro, El Palmar, Albacete, Ávila, Badajoz
2021-06-14
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
5,000
Albacete, Alcorcón, Alcoy, Alicante, Almería, Asturias, Badajoz, Barakaldo
2021-01-15
Active, closed
Daiichi Sankyo
Phase 3
1,600
Bilbao, El Palmar, Reus, A Coruña, Alcorcón, Alicante, Badajoz, Barcelona
2020-12-04
Active, closed
SyncAV Post-Market Trial
NCT04100148Congestive Heart Failure
Abbott Medical Devices
Not applicable
1,686
Badajoz, Barcelona, Madrid, Málaga, Salamanca
2019-10-03
Recruiting
University Hospital Muenster
Phase 3
683
Alicante, Almería, Badajoz, Barakaldo, Barcelona, Donostia / San Sebastian, Esplugues de Llobregat, Granada
2019-08-23
Active, closed
AstraZeneca
Phase 3
724
Badajoz, Barcelona, L'Hospitalet de Llobregat, Madrid, Málaga, San Sebastián, Santiago de Compostela, Seville
2019-03-06
Active, closed
Concordance Between FFR and iFR for the Assessment of Intermediate Lesions in the Left Main Coronary Artery. A Prospective Validation of a Default Value for iFR
NCT03767621Coronary Artery Disease, Left Main Coronary Artery Stenosis, Left Main Coronary Artery Disease, Restenosis, Coronary
Fundación EPIC
Observational
300
Terrassa, Cartagena, El Palmar, Castellon, Galdakao, Albacete, Badajoz, Badalona
2019-02-19
Active, closed
Fondazione Michelangelo
Phase 3
650
A Coruña, Alcoy, Alicante, Badajoz, Barcelona, Bilbao, Cáceres, Granada
2018-09-07
Active, closed
AstraZeneca
Phase 3
1,018
Badajoz, Barcelona, Elche(Alicante), Madrid, Málaga, Oviedo, Pamplona, Pozuelo de Alarcón
2018-05-14
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Badajoz, Badalona, Barcelona, Cáceres, Córdoba, Granada, Jaén, Las Palmas de Gran Canaria
2018-03-23
Recruiting
Spanish Breast Cancer Research Group
Observational
8,000
Pamplona, Avilés, San Cristóbal de La Laguna, A Coruña, Albacete, Alicante, Badajoz, Badalona
2018-01-18
Active, closed
AstraZeneca
Phase 3
987
A Coruña, Badajoz, Badalona, Barcelona, Madrid, Santander, Valencia, Zaragoza
2017-03-27
Active, closed
AstraZeneca
Phase 3
1,126
Badajoz, Badalona, Barcelona, Elche(Alicante), Madrid, Pozuelo de Alarcón, Santiago de Compostela, Seville
2015-11-02
Active, closed
Eli Lilly and Company
Phase 3
493
Badajoz, Barcelona, Donostia / San Sebastian, Lleida, Madrid, Valencia
2014-11-06
Active, closed
AstraZeneca
Phase 3
1,837
A Coruña, Ávila, Badajoz, Badalona, Barcelona, Castellon, Cáceres, Córdoba
2014-04-22
Recruiting
CHDI Foundation, Inc.
Observational
35,000
Badajoz, Barakaldo, Barcelona, Burgos, Madrid, Palma de Mallorca, Pamplona, Valencia
2012-07
Rows per page Showing 1–91 of 91
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/badajoz

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 91 of those studies with a site in Badajoz.

How many clinical trials are recruiting in Badajoz?

52 of the 91 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 3 have not yet opened recruitment, 36 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Badajoz), 91 studies
PhaseStudiesRecruitingShare
Phase 3512856%
Observational12713.2%
Phase 211412.1%
Not applicable848.8%
Phase 4333.3%
Phase 1222.2%
Phase 1/2222.2%
Phase 2/3222.2%

Most active sponsors

Lead sponsors with the most studies (Badajoz)
Lead sponsorStudiesRecruiting
AstraZeneca125
Eli Lilly and Company95
Fundación EPIC53
GlaxoSmithKline43
BioNTech SE33
SOLTI Breast Cancer Research Group32
Universidad de Extremadura31
Abbott Medical Devices21
AbbVie21
Celcuity Inc21
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.